You have 9 free searches left this month | for more free features.

City

Beverly Hills (1)

Los Angeles (1)

Shanghai (1)

Torrance (1)

Condition

Gastric Cancer (2)

Hepatocellular Carcinoma (1)

Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Andrew Hendifar, MD (1)

Taizhou EOC Pharma Co., Ltd. (1)

Collaborator

EOC Pharma (1)

Shanghai East Hospital (1)

Shanghai Zhongshan Hospital (1)

Intervention

telatinib (2)

capecitabine (1)

keytruda (1)

oxaliplatin (1)

placebos (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

telatinib

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Gastric Cancer, Hepatocellular Carcinoma Trial in Beverly Hills, Los Angeles, Torrance (Telatinib, Keytruda)

Recruiting

Gastric Cancer
Hepatocellular Carcinoma

Telatinib
Keytruda

Beverly Hills, California
+3 more

Sep 1, 2022

Gastric Cancer Trial in Shanghai (Telatinib, Capecitabine, Oxaliplatin)

Unknown status

Gastric Cancer

Telatinib
+3 more

Shanghai, China

Shanghai Easter Hospital

May 3, 2019